If there is only one interested party for a regional partnership then a $2 or 25cent share price wouldn’t make any difference to the outcome of a deal.
Any acceptable deal will need to have competitive tension and be based on what can be achieved out the back with a successful result of phase 3.
How did they arrive at the biosplice agreement or any other private campany deal with no publicly listed market cap?
I always see people suggest just buying the company for some low ball offer, it’s never that simple and with the register PAR have it wouldn’t happen.
Chart, page-4228
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.005(1.64%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $98.05K | 323.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29159 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |